An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
about
Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular diseaseRelationships between serum lipid, lipoprotein, triglyceride-rich lipoprotein, and high-density lipoprotein particle concentrations in post-renal transplant patients.Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohortLack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East ChinaLPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.Tryptophan probes reveal residue-specific phospholipid interactions of apolipoprotein C-IIIAn APOC3 3'UTR variant associated with plasma triglycerides levels and coronary heart disease by creating a functional miR-4271 binding site.Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry-based assay for serum apolipoproteins coupled to multi-marker ROC algorithmCharacterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response.Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism.Diagnosis and treatment of severe hypertriglyceridemia.Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.Looking into the crystal ball-upcoming drugs for dyslipidemia.Dual PPAR α / γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia.Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes.Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation.Advances in quantifying apolipoproteins using LC-MS/MS technology: implications for the clinic.Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
P2860
Q28075372-7BC1915A-EC37-40A0-8211-AD6F56AEA339Q33781024-8A58B816-6C0A-4FB9-8867-2C83D55665A5Q33781706-4011E442-C189-486D-A976-8274049A0875Q35565455-7D13ABC5-7CF1-4F2A-9D9B-002D74BB84FDQ35747811-417EBA60-45FA-4924-B476-3D619AD7324EQ36137606-076E606B-E93A-4441-AD95-14D3471346A6Q37254242-8FA3BA14-9A14-442A-9921-D06BC4E541DCQ37542168-66A041FF-34DB-4FBB-AE4A-2FFF9B073306Q37612440-5C1909D2-5843-4019-B2A5-9C3FD88FB696Q37857866-4ED6840A-5219-4906-9191-7C6B74C61455Q37998115-E9F263E4-5CF8-4EC8-A6A7-BF704019BB1EQ38076370-C812CD53-F816-4A55-95F0-939C26543D11Q38235611-2B872280-4FEC-4EBD-9394-48387BB4C970Q39826326-628E9AF8-435A-4D89-BD88-ED2F502C40A0Q41293822-4C54782D-E824-449B-BFC1-38A6ADBB51D8Q43225362-2BD65CAE-1EA7-4568-8578-354EF4609EFFQ47859533-0E462CD9-C5E4-4A7D-81E6-3433FAFBBF16Q54437683-F01536F3-CF5C-4041-AB4F-3E90F9031513
P2860
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
@en
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
@nl
type
label
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
@en
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
@nl
prefLabel
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
@en
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
@nl
P2093
P2860
P1476
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
@en
P2093
P2860
P304
P356
10.1111/J.1742-1241.2007.01678.X
P577
2008-01-14T00:00:00Z